Introduction
For many years, adipose tissue was regarded merely as a heat insulator and a store of excess free fatty acids (FFAs) that could be released when needed. However, following the identification of adipokines, adipose tissue is now recognized to play a central role in the pathophysiology of insulin resistance and metabolic syndrome 1) . Waist circumference, an easy-tomeasure marker of metabolic risk and used to define metabolic syndrome, has been shown to correlate with different components of the syndrome supporting the notion that visceral obesity plays an important role in the development of cardiovascular diseases as well as insulin resistance and type 2 diabetes. Several recent studies have increased the understanding of adipose times more subcutaneous than visceral adipose tissue 3) , and it appears that these two tissue types can interact in a coordinated and compensatory manner 4) . Although WAT and BAT share many metabolic characteristics, WAT stores energy whereas BAT dissipates energy. The role of BAT in adult humans is unclear but it has been recently proposed that it can be induced to increase glucose uptake 5) . Furthermore, genes characteristic of human BAT have been shown to negatively correlate with obesity and insulin sensitivity 6, 7) .
Adipose Tissue as an Endocrine Organ
Adipose tissue is a key endocrine organ with autocrine regulation. It has a central role in obesityassociated complications such as dyslipidemia, insulin resistance and type 2 diabetes as well as low-grade inflammation and increased risk of cardiovascular disease and metabolic syndrome 8) . It is now established that adipose tissue comprises ~50% adipocytes and ~50% other cells including preadipocytes, vascular, neural and immune cells and leucocytes 9) . The adipocytes, preadipocytes and macrophages within adipose tissue secrete a wide range of hormones and cytokines, including interleukin (IL)-6, IL-8, IL-1 and monocyte chemoattractant protein (MCP)-1 2) . It is now evident that many of these adipokines have the ability to influence other tissues such as the liver and muscle. Furthermore, the adipokine leptin affects appetite regulation, and others have an important impact on inflammation and vascular biology (Fig. 1) .
The Adipocyte
The adipocyte is a very complex cell. Under normal conditions, it is involved in lipid synthesis, storage and secretion of anti-inflammatory molecules, but it can also be induced to secrete a number of inflammatory factors such as MCP-1 and IL-6. By acting as transmitters of endocrine or paracrine signals, the secreted adipokines can promote either inflammation or altered insulin sensitivity of the adipocyte (Fig. 2) .
Fat mass is dependent on both adipocyte cell number and size. The number of adipocytes is determined during early adulthood and changes in fat mass are attributed to changes in adipocyte cell size 10) . The adipocyte turnover rate in humans was recently established to be ~10% per year 10) . Fat cell mass increases with increasing body fat to a maximum of ~0.7 − 0.8 g lipids per cell, and thereafter there is a more rapid increase in fat cell number 11) . In subjects with obesity, adipose tissue has a lower capacity for the recruitment of new adipocytes 12) . Tschoukalova et al. found that the number of committed preadipocytes was decreased in patients with obesity independent of fat location 13) . In a recently published study from our laboratory, we found that the number of mesenchymal precursor cells was increased in obese individuals but differentiation of preadipocytes into adipocytes was decreased, suggesting an impaired differentiation of preadipocytes in obesity 2) . Therefore, it appears that most adultonset obesity is related to the hypertrophy of adipocytes, and enlarged adipocytes is the best obesity-fac- Adipose tissue is a key endocrine organ that releases several adipokines capable of affecting other tissues and playing an important role in the pathophysiology of insulin resistance and metabolic syndrome. Under normal conditions, the adipocyte is a site of lipid synthesis, uptake and storage. Secreted adipokines function as either endocrine, paracrine or autocrine mediators. Increases in adipocyte size can lead to deleterious alterations in insulin sensitivity caused by a decrease in adiponectin secretion, an increase in the release of FFAs and the induction of inflammatory mediators.
tor in correlation with insulin resistance compared with other factors related to obesity 1, 14) . Large adipocytes are more insulin-resistant and lipolytic, and release more inflammatory cytokines and less adiponectin (Fig. 2) 
15)
. They are also more frequently found in individuals with obesity-related metabolic disorders 11) . Thus, the relative number of large adipocytes might be the most important determinant of metabolic activity and the response to environmental changes.
Features of Metabolic Syndrome
The term "metabolic syndrome" includes hypertension, dyslipidemia, glucose intolerance and insulin resistance, variables that all are associated with obesity 16) . Dysfunctional adipose tissue with low-grade, chronic and systemic inflammation links the metabolic and vascular pathogenesis including dyslipidemia, low-grade inflammation and insulin resistance and is a hallmark of disorders such as type 2 diabetes and cardiovascular disease (Fig. 3) . However, lifestyle factors and, to a lesser degree, genetic factors, are also involved 17) .
Visceral and Subcutaneous Adipose Tissue
A high level of visceral fat is an independent risk factor for glucose intolerance, insulin resistance, and cardiovascular disease. Visceral fat refers to the intraperitoneal fat composed of the greater and lesser omentum and mesenteric adipose tissue. Visceral fat accounts for ~20% of total body fat in men compared with only ~6% in pre-menopausal women. A male risk profile has been characterized in women with abdominal obesity 11) . Enlarged adipocytes in the viscera are characterized by an increased lipolytic state and are resistant to the anti-lipolytic effects of insulin 18) . Waist circumference is an index of the body's periarterial and periarteriolar fat. It is an easy-to-measure marker of metabolic risk and is used to identify individuals with metabolic syndrome. However, the adverse and contributing effects of abdominal subcutaneous fat should not be overlooked as up to 80% of total adipose tissue can be composed of subcutaneous fat 19) . Visceral and subcutaneous adipose tissue deposits have constitutive biological differences that are characteristic of their physiological roles. Even though both deposits serve as energy reservoirs to maintain systemic equilibrium, there are differences in levels of lipid mobilization, adipokine production and adipocyte differentiation that might be of importance in responses to diet and exercise 20) . Visceral fat secretes higher levels of complement factors, adiponectin, and inflammatory markers such as IL-6, IL-8, angiotensinogen and plasminogen activator inhibitor-1 4, 21, 22) . Rates of FFA lipolysis are approximately 50% greater in obese individuals than in healthy subjects, and higher in subjects with upper body obesity than those with lower body obesity. However, abdominal subcutaneous fat is probably the main source of increased levels of circulating FFA 20) . The altered FFA metabolism and endocrine function in visseral obese individuals imply that visceral adipose tissue is involved in the pathophysiology of metabolic syndrome but this does not exclude a contribution from subcutaneous adipose tissue.
TNF and IL-6
Several studies suggest that tumour necrosis factor (TNF) and IL-6 are both involved in obesityrelated insulin resistance and that TNF is one of the most important mediators of inflammation 23) . In contrast to IL-6, TNF is secreted not by adipocytes but instead by infiltrating macrophages in adipose tissue, and functions as a paracrine and/or autocrine factor 24, 25) . It has been shown that adipose tissue is a significant source of circulating IL-6 and also related to BMI and adipocyte size 15) . TNF and IL-6 are known to promote lipolysis and the secretion of FFA, which contribute to an increase in hepatic glucose production and insulin resistance 26) . Both cytokines impair adipocyte differentiation and instead promote inflam- Metabolic syndrome refers to several known risk factors including insulin resistance, obesity, dyslipidemia and hypertension. The conditions are interrelated and share underlying mediators. Individuals who have the same underlying malfunctions are at high risk of developing type 2 diabetes and cardiovascular disease. mation 27) . Furthermore, IL-6 promotes inflammation not only in adipose tissue but in endothelial cells and liver cells 28) . IL-6 also promotes insulin resistance by interfering with the insulin signaling in adipose tissue 29) . In a recent study in obese individuals, adipokine levels in the radial artery were compared with those in the portal circulation to evaluate the possibility that visceral fat supports systemic inflammation by secreting inflammatory cytokines into the portal circulation that drains visceral fat 22) . The authors found a 50% increase in the secretion of IL-6 into the portal vein, but no other differences among the inflammatory adipokines tested. They also found a direct correlation between the concentrations of IL-6 and systemic C-reactive protein (CRP) in the portal vein. These findings indicate that visceral fat is an important site for IL-6 secretion and provide a potential link between visceral fat and systemic inflammation in individuals with abdominal obesity 22) . A further study in overweight men showed that circulating levels of IL-6 were associated with visceral adiposity, whereas TNF showed an association with overall obesity 30) . These results support the hypothesis that IL-6 mediates the hyperinsulinemic state related to excess visceral fat while TNF seems to contribute to the insulin resistance of overall obesity 30) .
Ectopic Fat Accumulation
Ectopic fat is defined as the deposition of triglycerides within cells of non-adipose tissue that normally contain only small amounts of fat. A positive energy balance produces a pattern similar to lipodystrophy with the accumulation of excess lipids in the liver, skeletal muscle and pancreas indicating that adipose tissue is not capable of sequestering nutritional lipids away from these organs 31) . The accumulation of fat in skeletal muscle and viscera is associated with insulin resistance and cardiovascular disease.
Lipid accumulation in liver and muscle is an early hallmark of type 2 diabetes. In the pancreas, lipid accumulation has been shown to precede suppressed glucose-mediated insulin production 32) . In the lipid-overloaded heart, metabolic dysregulation may induce insulin resistance resulting in impaired glucose oxidation and, ultimately, heart failure 33) . The accumulation of ectopic fat is now considered part of metabolic syndrome. However, although the evidence for its deleterious effects is strong, whether ectopic lipid accumulation precedes or succeeds insulin resistance is not clear.
Epicardial Adipose Tissue
Epicardial adipose tissue is metabolically active and a source of FFA and several bioactive adipokines such as adiponectin, TNF , IL-1, IL-6, neural growth factor and resistin 34, 35) . Some of these factors might substantially affect cardiovascular function and morphology and, thereby, directly contribute to the development of the cardiovascular complications of increased adiposity as well as insulin resistance 34, 35) . Epicardial fat reflects cardiac and visceral adiposity and is related to intima-media thickness, an increase in vascular stiffness, and inflammation which plays a major part in disease progression 36, 37) . Individuals with coronary artery disease show increased macrophage infiltration into epicardial fat, suggesting a state of chronic inflammation 38) . Epicardial adipose tissue may also affect the coronary arteries and myocardium through paracrine and/or direct secretion of pro-inflammatory adipokines. Epicardial fat has a higher rate of FFA and triacylglycerol uptake than subcutaneous fat, but also a higher rate of fatty acid breakdown 39) .
Perivascular Fat
Perivascular adipose tissue (PAT) surrounds blood vessels in changing amounts and is produced from the vascular lamina adventitia in response to circulating factors and local stimuli 40) . PAT has been considered largely a passive structural support for arteries. However, it can play an active role in regulating vascular tone and releases adipocytederived vascular relaxation factors into blood vessels 41) . Excess calories and inactivity enlarge PAT depots with potentially unfavorable consequences and an increase in PAT is suggested to mediate morphologic changes associated with an increase in vascular stiffness seen in obesity 42) .
Insulin Resistance
Large adipocytes are more frequently found in subjects with impaired glucose tolerance and type 2 diabetes than those with a similar degree of adiposity but with normal glucose tolerance, and impaired adipocyte differentiation appears to be one of the most important factors in the progression of type 2 diabetes 1) . Insulin has several functions, including the transport of nutrients into cells, the regulation of gene expression and energy homeostasis. It acts on a number of target tissues and through many different intracellular signaling cascades. Elevated levels of intracellular FFAs can blunt the response to insulin and sub-sequent metabolic effects 43) . Insulin receptor substrate (IRS)-1 is a key molecule in the insulin signaling pathway, and failure to activate IRS-1 leads to systemic insulin resistance 44) . Inhibitory phosphorylation of IRS-1 can be induced through inflammatory agents such as TNF and IL-6, but also through activation of receptors such as the Toll-like receptors (TLR), or intracellular molecules such as lipids and reactive oxygen species (ROS). Activation of the TNF and IL-6 receptors induces activation of important activators of inflammation i.e. I B kinase (IKK ) and Janus kinase (JNK). JNK is also activated by FFAs and endoplasmatic reticulum stress, factors that are associated with obesity-induced activity. IKK does not phosphorylate IRS-1 but causes insulin resistance through activation of NF B 45) . Suppressor of cytokine signalling (SOCS) inhibits insulins actions on IRS-1 either by interfering with the tyrosine phosphorylation or by targeting IRS-1 for proteosomal degradation 44, 46) . The consequences of decreased insulin production as a result of ectopic lipid accumulation in the pancreas combined with a diminished activation of the insulin receptor in adipocytes results in an impairment of insulin-stimulated glucose transport, a reduced anti-lipolytic effect, an increase in the amount of FFA released, impaired preadipocyte differentiation and a decrease in lipoprotein lipase production and activity. These effects will lead to the development of insulin resistance, type 2 diabetes and cardiovascular diseases.
Macrophage Infiltration into Adipose Tissue
There are two kinds of macrophages in adipose tissue: resident/tissue (or alternatively activated) macrophages and inflammatory macrophages. In severely obese individuals, the number of macrophages is higher in visceral fat than subcutaneous fat 47) , consistent with a more prominent role for visceral fat in insulin resistance 48) . The infiltration of monocytes/ macrophages into adipocyte tissue is probably initiated by an increase in adipocyte size (Fig. 4) . Enlargement of adipocytes is associated with an increase in physical stress and ROS production, and increased secretion of FFA and inflammatory cytokines 2, 49) . Of these cytokines, MCP-1 secreted from macrophages seems to be the most important 2, 49) . MCP-1 is expressed before inflammatory macrophage markers 50) , providing evidence that cells other than macrophages produce it. In obesity, circulating mononuclear cells are in a proinflammatory state and are key players in endothelial dysfunction. The transmigration of blood monocytes into adipose tissue is a complex mechanism that requires the expression of adherent molecules both on the monocytes and on the endothelial cells to which they attach 51, 52) . After transmigration into adipose tissue, the monocytes differentiate into inflammatory macrophages.
Infiltrating inflammatory macrophages constitute a major source of inflammatory mediators, especially TNF , within adipose tissue, and it is likely that they Enlargement of adipocytes is associated with an increase in the release of FFAs, physical stress and increased ROS production. These stress factors induce production of inflammatory adipokines such as IL-6, serum amyloid A (SAA) and MCP-1 that are released into the circulation and mediate the recruitment of activated monocytes into adipose tissue. The monocytes differentiate into inflammatory macrophages that release TNF . TNF induces further inflammation in the adipocytes and recruitment of macrophages.
act synergistically with adipocytes to amplify local inflammation 53) . Neutralizing antibodies to TNF have been shown to inhibit inflammation in a coculture of 3T3-L1 adipocytes and a macrophage cell line, suggesting that TNF is a major macrophage-derived mediator of inflammation in adipocytes 54) . Resident macrophages have low levels of proinflammatory cytokine production but can be activated with an enhanced recruitment and activation of blood monocytes 52) . The infiltration of macrophages into adipose tissue contributes to the local and systemic metabolic effects of obesity, however, the majority of macrophages are distributed around necrotic adipocytes whose numbers increase dramatically in obese individuals. For example, Cinti et al. showed that 90% of all macrophages in the adipose tissue of obese individuals were located around dead adipocytes 55) . They also showed a positive correlation between adipocyte death and adipocyte size and suggested that adipocyte death helps to mediate local macrophage infiltration 55) . It is proposed that the inflammation in adipocytes entails a paracrine loop involving FFAs released from adipocytes and TNF released from macrophages, which, together with other factors, leads to a further increase in recruitment of monocytes 54) .
Vasocrine Signaling
Excess intake of calories results in increased deposition of perivascular fat around the heart and its major branches. Conditions where there is an increased amount of adipose tissue surrounding the blood vessels, overproduction of adipokines, and signaling from perivascular fat deposits to the arteries, "outside-toinside signalling", could than lead to inflammation and atherosclerosis (Fig. 5) . Perivascular fat is also considered to be ectopic within adipose tissue, acting as an integrated organ responsible for both paracrine signaling and vessel-to-vessel signaling "vasocrine signaling". Insulin has the rapid effect of increasing blood flow to skeletal muscle and an ability to recruit capillaries that depends on its actions to dilate precapillary arterioles 56) . The most potent inhibitor of insulin's actions and endothelial nitrogen oxide (NO)-dependent vasodilation among cytokines is TNF , and it is suggested that a high local concentration of cytokines leads to a blunted activation by insulin of endothelial NO synthase and increased release of endothelin-1, resulting in a constriction of the arteriole 40) . Increased amounts of perivascular adipose tissue around vessels secrete vasoactive substances that can both generate local inflammation and alter vascular function. A balance between the perivascular adipose tissue-derived vasodilator and vasoconstriction factors is essential for maintaining normal vascular tone. Increased secretion of vasocrine substances can lead to the increased release of endothelin-1 at the expense of NO and here insulin has a dual function, modulation of NO synthesis and release of endothelin-1.
Effects of Adiponectin
In 1995 and 1996, four different groups independently identified adiponectin [57] [58] [59] . Belonging to the complement 1q family, adiponectin forms characteristic multimers of which the high molecular weight (HMW) multimer seems to be the most important 60, 61) . The ratio of the HMW multimer to other forms is an independent risk factor for metabolic disorders 62) . Adiponectin is abundantly expressed in adipose tissue and circulating levels are high, 5 to 20 g/mL. Adiponectin levels negatively correlate with visceral adiposity to a greater extent than with subcutaneous adiposity.
Kim et al. showed that although overexpression of adiponectin in ob/ob mice results in normalized glucose and insulin levels together with improvements in triglyceride and FFA levels, the mice became extremely obese due to adipocyte hyperplasia 63) . Despite the obesity, very few macrophages were present in adipose tissue, consistent with increased differentiation of new insulin-sensitive adipocytes 63) .
Adiponectin and the Vascular System
Adiponectin has effects in a number of different tissues. For example, in muscle, it counteracts insulin resistance 64) . In arteries, it reduces atherosclerosis and intima media thickness 65) . It also has effects on capillaries and the heart 61) . The actions of adiponectin are summarized in Fig. 6 .
Adiponectin attenuates inflammatory actions at several levels. It reduces TNF -stimulated expression of E-selectin, vascular cell adhesion molecule-1 (VCAM-1) and IL-8 in human aortic endothelial cells [66] [67] [68] . It also inhibits TNF -induced activation of nuclear factor-B (NF B) and prevents the proliferation and migration of smooth muscle cells. Adiponectin inhibits foam cell formation (lipid accumulation in macrophages) as well as platelet aggregation and T-cell recruitment and accumulation 69) . It has been shown to inhibit Toll-like receptor-mediated activation of NF B in mouse macrophages 70) . Adiponectin is also an important regulator of endothelial NO synthase, a major determinant of endothelial function and angiogenesis 71) .
Conclusion
Adipose tissue is a central factor in the development of insulin resistance and regulation of wholebody insulin sensitivity. It is also plays an important role in vascular complications. Adipose tissue has the ability to modulate both local and systemic processes in other tissues such as the liver, pancreas, skeletal muscle, heart and brain. An increase in adipose tissue mass results in the infiltration of macrophages and enhanced inflammation. Adipokines produced by the adipose tissue impair insulin signalling and key proteins for glucose uptake. In addition, secreted adipokines promote endothelial dysfunction, adhesion of monocytes, vascular remodelling and foam cell formation in the arterial wall, which contribute to cardiovascular complications. The reduction in adiponectin levels with increasing adiposity contributes to obesityassociated vascular complications. 
